Us Bancorp \De\ Next Cure, Inc. Transaction History

Us Bancorp \De\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$6.74 - $8.02 $2,642 - $3,143	-392 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$7.6 - $10.28 $1,884 - $2,549	248 Added 172.22%	392 $3,000
Q1 2021 Apr 28, 2021	BUY	$9.81 - $13.88 $362 - $513	37 Added 34.58%	144 $1,000
Q4 2020 Feb 04, 2021	BUY	$9.47 - $12.43 $1,013 - $1,330	107 New	107 $1,000
Q3 2020 Nov 10, 2020	SELL	$8.15 - $21.17 $383 - $994	-47 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$21.19 - $40.2 $995 - $1,889	47 New	47 $1,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.